Charles S. Hrushka
Keine laufenden Positionen mehr
Profil
Charles S.
Hrushka served as the Managing Director at ScheBoBiotech USA, Inc. from 2001 to 2004.
He was the President & Chief Operating Officer at Burren Pharmaceuticals, Inc. from 2004 to 2005.
He also worked as the Vice President-Marketing at Sucampo Pharmaceuticals, Inc. and as the Vice President-Sales & Marketing at Pernix Therapeutics Holdings, Inc. Hrushka holds an MBA from Georgia State University and an undergraduate degree from the University of Lynchburg.
Ehemalige bekannte Positionen von Charles S. Hrushka
| Unternehmen | Position | Ende |
|---|---|---|
| PERNIX THERAPEUTICS HOLDINGS INC | Vertrieb & Marketing | 18.01.2013 |
| Burren Pharmaceuticals, Inc. | Präsident | 01.12.2005 |
| ScheBoBiotech USA, Inc. | Corporate Officer/Principal | 01.09.2004 |
| SUCAMPO PHARMACEUTICALS, INC. | Vertrieb & Marketing | - |
Ausbildung von Charles S. Hrushka
| Georgia State University | Masters Business Admin |
| University of Lynchburg | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
| Burren Pharmaceuticals, Inc. | |
| ScheBoBiotech USA, Inc. | |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
